Locations:
Search IconSearch
July 31, 2017/Digestive

Images of Note: Grey Turner and Cullen Signs

Ecchymoses from hepatocellular carcinoma

By Sharon Mace, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

A 60-year-old man with hepatocellular carcinoma was admitted to the hospital with pulmonary emboli secondary to inferior vena caval thrombosis that extended to the right atrium.

Figure 1. Cullen sign.

He became hypotensive on the second day, with a heart rate of 124 per minute, respiratory rate 44 per minute, pulse oxygen saturation 79 percent on room air, and systolic blood pressure 70 mm Hg. Physical examination revealed abdominal ecchymoses resembling the Cullen sign and flank ecchymoses resembling the Grey Turner sign (Figures 1 and 2).

Figure 2. Grey Turner sign.

He was given a bolus of normal saline followed by infusion of fresh frozen plasma and packed red blood cells. His lactate level was 17.52 mg/dL (reference range 0.1–2.2). His hemoglobin and hematocrit decreased precipitously — the hemoglobin from 10.5 g/dL to 5.9 (reference range 14.0–17.5), and the hematocrit from 30.3 percent to 17.8 percent (reference range 41–50). He was transferred to the intensive care unit. A do-not-resuscitate order was instituted, and he died 12 hours later.

Conditions resulting in the Cullen and Grey Turner signs

The Cullen sign, a bluish discoloration of the periumbilical skin, was originally described in 1918 by the gynecologist Thomas Cullen, MD, in a patient with a ruptured ectopic pregnancy. The Grey Turner sign, an ecchymotic discoloration of the lateral abdominal wall or flank, was first reported in 1920 by a surgeon, Dr. George Grey Turner, in a patient with acute pancreatitis.

The signs occur in about 1 percent of patients with acute pancreatitis and predict a poor prognosis, with a reported death rate of 37 percent.

Advertisement

The appearance of ecchymoses in the periumbilical area or flank has been taught as a hallmark of acute pancreatitis. However, the original patient described with the Cullen sign did not have pancreatitis, and it has been reported with many other conditions, including ruptured aortic aneurysm, splenic rupture and rectus sheath hematoma; as a complication of anticoagulation or perforated duodenal ulcer; and, as in our patient, as a manifestation of liver disease.

How they occur

The common pathway leading to the occurrence of these subcutaneous ecchymoses is retroperitoneal bleeding followed by tracking of blood from the retroperitoneum through a defect in the transversalis fascia to the abdominal wall musculature and then to the periumbilical subcutaneous tissue. In the Cullen sign, blood diffuses from the retroperitoneum along the gastrohepatic and falciform ligaments to the umbilicus. In the Grey Turner sign, blood diffuses from the posterior pararenal space to the lateral edge of the quadratus lumborum muscle. Blood from a retroperitoneal hemorrhage may also diffuse and pool at the inguinal ligament (Fox sign) or at the scrotum (Bryant sign).

The time to the appearance of the Cullen or the Grey Turner sign is thought to be at least 24 hours after the onset of retroperitoneal bleeding and averages about three days after the onset of pancreatitis.

Dr. Mace is staff in the Center for Emergency Medicine.

This article originally appeared in the Cleveland Clinic Journal of Medicine.

Advertisement

Related Articles

Closeup of bariatric surgery
November 18, 2024/Digestive/Research
Dramatic Microbiome Change Predicts Weight Loss Effectiveness After Metabolic Bariatric Surgery

Findings could help identify patients at risk for poor outcomes

Nurses entering information onto computers
November 8, 2024/Digestive/Research
Study Shows SGLT2i Drugs Are Safe for Patients with Cirrhosis

Findings also indicate reduced risk of serious liver events

Physician speaking with patient by computer
November 6, 2024/Digestive/Research
Model Uses Machine Learning to Predict Patients at Risk of Gastric Cancer

Promising results could lead to improved screening, better outcomes

Patient holding stomach
October 31, 2024/Digestive/Research
IVIG Therapy Shows Promise in Reducing Symptom Severity for AGID

Significant improvement in GCSI scores following treatment

Doctor speaking with patient
October 29, 2024/Digestive/Research
RSV Vaccination Lowers Risk for IBD Patients Over 60, Study Finds

Despite benefits, vaccination rates remain low for high-risk population

Closeup of physician performing bariatric surgery
October 8, 2024/Digestive/Research
Consider Weight Loss Surgery as a Treatment for Chronic Kidney Disease, Obesity

Findings show greater reduction in CKD progression, kidney failure than GLP-1RAs

Physician speaking with patient
The Mind-Gut Connection: How Behavioral Health Specialists Improve GI Care at Cleveland Clinic

Customized interventions for diverse GI disorders are enhancing patient outcomes

Pills in packaging
September 9, 2024/Digestive
Functional Dyspepsia: How to Manage the Burn and the Bloat (Part II)

Guidance on medications and treatment options

Ad